Westin Tom, MD, BA

CA1 Resident
Wollin DA, Davis LG, Winship BB, Carlos EC, Tom WR, Asplin JR, Kosinski AS, Scales CD, Ferrandino MN, Preminger GM, Lipkin ME. Assessment of conservative dietary management as a method for normalization of 24-h urine pH in stone formers. Urolithiasis. 2019 May 06.
Wollin DA, Tom WR, Jiang R, Simmons WN, Preminger GM, Lipkin ME. An in vitro evaluation of laser settings and location in the efficiency of the popcorn effect. Urolithiasis. 2018 Jun 15.
Wollin DA, Carlos EC, Tom WR, Simmons WN, Preminger GM, Lipkin ME. Effect of Laser Settings and Irrigation Rates on Ureteral Temperature During Holmium Laser Lithotripsy, an In Vitro Model. J Endourol. 2018 01; 32(1):59-63.
Tom WR, Wollin DA, Jiang R, Radvak D, Simmons WN, Preminger GM, Lipkin ME. Next-Generation Single-Use Ureteroscopes: An In Vitro Comparison. J Endourol. 2017 12; 31(12):1301-1306.
Kregel S, Chen JL, Tom W, Krishnan V, Kach J, Brechka H, Fessenden TB, Isikbay M, Paner GP, Szmulewitz RZ, Vander Griend DJ. Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer. Oncotarget. 2016 May 03; 7(18):26259-74.
Gillard M, Tom WR, Antic T, Paner GP, Lingen MW, VanderWeele DJ. Next-gen tissue: preservation of molecular and morphological fidelity in prostate tissue. Am J Transl Res. 2015; 7(7):1227-35.
VanderWeele DJ, Brown CD, Taxy JB, Gillard M, Hatcher DM, Tom WR, Stadler WM, White KP. Low-grade prostate cancer diverges early from high grade and metastatic disease. Cancer Sci. 2014 Aug; 105(8):1079-85.
Kregel S, Kiriluk KJ, Rosen AM, Cai Y, Reyes EE, Otto KB, Tom W, Paner GP, Szmulewitz RZ, Vander Griend DJ. Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer. PLoS One. 2013; 8(1):e53701.